KBP-5074
Stories
-
Novo Nordisk posts results of Phase 3 KBP-5074 trial in uncontrolled hypertension and CKD
The study enrolled 666 participants and began on November 5, 2021, with primary completion on January 30, 2024. The trial was terminated and the results were first posted on ClinicalTrials.gov on November 4, 2026.